Mar 9 2010
X-spine Systems, Inc., a global manufacturer of implants and instruments
for spinal surgery, announced today that it has entered into an
exclusive license agreement with Gamma Spine for the development and
distribution of its minimally invasive spinal fixation technology. Gamma
Spine, founded by Dr. Vijay Goel, Ph.D., will participate in the
development process with X-spine. “I am thrilled be working with Dr.
Goel, who is one of the world’s most renowned and published experts in
spinal biomechanics, to develop this unique and valuable technology,”
stated Dr. David Kirschman, President and CEO of X-spine. The
patent-pending device allows for the fixation of adjacent vertebral
segments with minimal tissue disruption while attaining the
biomechanical advantages of a traditional full-exposure system.
“I am thrilled be working with Dr.
Goel, who is one of the world’s most renowned and published experts in
spinal biomechanics, to develop this unique and valuable technology”
“X-spine is the ideal partner to bring this technology to the worldwide
marketplace; the company has an excellent track record of bringing
innovative technology to fruition through its top-down emphasis on
engineering, research, and development,” stated Dr. Goel. In addition to
his duties as principal of Gamma Spine, Dr. Goel is the Endowed Chair &
McMaster-Gardner Professor of Orthopaedic Bioengineering at the
University of Toledo, Ohio.
By entering into this license agreement, X-spine furthers its strategy
to address the continuing market trend towards smaller, cost-effective
procedures in spinal surgery. “Surgeons are demanding procedure options
which are less invasive for patients, less costly for payers, but
maintain the ease, safety and efficacy of traditional full-exposure
procedures,” states Dr. Kirschman. “We feel that the Gamma technology
effectively addresses that demand.”